.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Prof. Dr. Stephan Becker

Further involvements

13/02/2025
Poster
P-1-50
A combination of direct acting and host-directed antivirals dramatically suppresses various Coronaviruses
Immune Prevention and Therapy
13/02/2025
Poster
P-1-52
Implementing mRNA technology at DZIF: Benchmarking vaccines against three human pathogens of public health importance
Immune Prevention and Therapy
13/02/2025
Poster
P-1-83
IGHV1-69 dominated memory B cell response upon MVA-MERS-S vaccination targets multiple neutralizing and non-neutralizing epitopes
Immune Prevention and Therapy
13/02/2025
Poster
P-1-88
Modified vaccinia virus Ankara-based vaccine candidates provide cross-protection against lethal MARV challenge in a single-dose vaccination regimen
Immune Prevention and Therapy
14/02/2025
Poster
P-2-16
Self-amplifying RNA vaccine protects mice against lethal homologous and heterologous CCHFV infection
Tropical and Emerging Infections
14/02/2025
Poster
P-2-42
Long-term immunogenicity of the MVA-MERS-S vaccine candidate in humans
Tropical and Emerging Infections
14/02/2025
Poster
P-2-43
Systems vaccinology reveals enhanced innate and T follicular helper cell responses after a late third MVA-MERS-S vaccination in humans
Tropical and Emerging Infections
14/02/2025
Poster
P-2-49
Rapid development of Modified Vaccinia virus Ankara (MVA)-based vaccine candidates against Marburg virus suitable for clinical use in humans
Tropical and Emerging Infections
14/02/2025
Poster
P-2-52
Developing broad-spectrum antivirals against emerging viral threats: A systematic approach using the antiviral compound testing platform
Tropical and Emerging Infections
14/02/2025
Poster
P-2-55
Investigating sex differences following vaccination with an MVA-based vaccine against the Middle East Respiratory Syndrome (MERS)
Tropical and Emerging Infections